Fig. 4.
Impedance measurements of adenocarcinomic human alveolar basal epithelial cells (A549) in the microfluidic device originally designed in the “GEMNS” project (EuroNanoMed II program) by the Nanotoxicology group at the University of Bergen, Norway. Please see video information for A549 cells in the microfluidic device set-up (Additional file 1)